Biotech

Aim to spur India's bio economy to an aspirational $300 billion by 2030

Aligned to the recently approved BioE3 policy, the partnership will fast-track innovation and tech-driven support in the…

eGenesis is working on a genome engineering-based approach to the development of safe and effective transplantable organs with the…

Pegfilgrastim is a Pegylated form of the recombinant human granulocyte colony-stimulating factor (G-CSF) analogue Filgrastim

Ivor Campbell, Chief Executive, Snedden Campbell, a specialist recruitment consultant for the medical technology industry…

Ongoing biomarker analysis may help clarify which patients could benefit most from alisertib Puma Biotechnology, announced the…

The partnership aims to advance BGTC’s mission to develop platforms and standards to propel the development and delivery of…

Deal includes DTx-1252, a potential therapy for the neuromuscular disorder Charcot-Marie-Tooth disease type 1A (CMT1A), and two…

CSL makes most of its money paying people in the United States (US) for blood plasma, which it uses for treatments of rare…

1,100 biotech startups emerged in the last year itself, Prime Minister Narendra Modi said

Park to act as hub for incubation of new ideas, and will support agri-entrepreneurs, startups, progressive farmers, scientists and…

Speaking during the launch of Biological Research Regulatory Approval Portal (BioRRAP), Dr Singh said, India is poised to become a…

The programmes will support the start-up ecosystem, academia, new ventures and biopharmaceutical projects

She has taken over responsibilities from Dr Vasan Sambandamurthy with effect from 1st December, 2021 till further communication

The outsourcing market size for CDMOs in India is roughly at Rs 20,000 crores and it is expected to grow to about Rs 40,000 crores…